With the help of Crispr, the world’s first gene editing technology, scientists have developed a new tool that can make it easier for doctors to identify and treat diseases.
The development could revolutionize the way doctors diagnose disease and save lives, said Michael J. Gebbia, a professor of surgery at Harvard Medical School and the author of “The Good Gene.”
“You can look at a patient and say, ‘What is this disease that is causing these symptoms?
What does this disease do?'”
“It’s like a doctor using a microscope to see if there’s any disease.
Now you can take that same microscope to a patient, look at their blood and see if that’s the disease.
It’s like having a microscope that can look more closely at a problem.”
Gebbi, who was not involved in the research, said he was inspired to start his own research company after his son, who had leukemia, developed a rare form of the disease called lymphoma.
The research was published in the journal Cell.
“When he developed leukemia, I had the chance to spend a year working with him, and he got very sick.
I was very worried about him,” said Dr. G. Daniel Kornblau, a medical doctor who specializes in genetic engineering and who has also worked on gene editing and cancer research.”
He’s one of the lucky ones.
He has a great life.”
Dr. Gebra said the technique he used was based on a technique called CRISPR-Cas9, which was developed by the team at the University of Pittsburgh.
The technology works by inserting DNA sequences into cells, and then cutting them out of the cells.
It then takes the DNA and replicates it into other cells, which then carry out the instructions for the new DNA.
The technology has already been used to create tiny embryos that are implanted in mice, but the scientists wanted to see how it would work in humans.
“The key idea here is that this technology allows you to use the entire genome of a patient,” Gebbi said.
“What we did is, we used CRISPA-Cas10 to introduce into the cell DNA sequences from a patient’s own cells and insert them into a mouse embryo.
The result was an embryo that’s genetically identical to the patient.
That embryo then gets injected into a patient.”
Gebra said his team has already begun working on ways to develop the technology to create new forms of stem cells, or cells that would be more suitable for the treatment of certain diseases.
“That could be used to regenerate tissue or organs or other cells in the body.
It could be a new generation of therapeutic stem cells,” he said.
In the meantime, Gebbe said it was possible to use CRISpr to make embryos of any age, from newborns to old age.
“There’s a huge amount of potential here,” he added.
“I think it’s going to have huge impact on the way we treat and diagnose diseases in this day and age.”